Clinical trial NCT01131715: Pharmacist Follow-up, a Qualitative Study of Patient Experience
Official title: Pharmacist Follow-up of Patients With Coronary Heart Disease. A Qualitative Study of Patient Experience.
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Patient Satisfaction
Patient Preference
Keywords: Qualitetive interview
Coronary heart disease (CHD)
Patient experience
Patient perception
Lead sponsor: Hospital Pharmacy of North Norway Trust
Sponsor class: OTHER
Collaborators: name: University of Tromso
First posted: 2010-05-27
Enrollment: 4
Sex: ALL
Minimum age (years): 18
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: OTHER
Time perspective: OTHER
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients included in the study "Pharmacist follow-up of patients with CHD".

Brief summary: A pharmacist follow-up procedure is under development. Patients with coronary heart disease (CHD) is being followed up by a pharmacist for one year with three meetings; at discharge from hospital, after three months and after one year. The evaluation is basically based on quantitative measures as achievement of therapeutic goals, number of drug related problems detected, hospitalisations etc. However, the patients' own experience with the follow-up procedure cannot be evaluated using these measures. Thus, a qualitative approach is needed. In this study, a total of four patients participating in the follow-up will be included and interviewed. A semistructured interview guide will be used. Interviews will be taped, transcribed and analyzed with the intention to explore how patients experience the follow-up from the pharmacist. A thoruough content analysis will be performed. Patients included must have met the pharmacist at least twice. The pharmacist in charge of the follow-up will recruit patients and hand out study information. Patients will reply to the principal investigator of the study and thus kept anonymous for the pharmacist in charge of the follow-up. No pressure will be put on the patients to join, but it will be emphasized that it will help evaluating the procedure.

Detailed description: See full publication on http://www.biomedcentral.com/1756-0500/7/197 Garcia et al. BMC Research Notes 2014, 7:197

Eligibility criteria: Inclusion Criteria:

* must have met the pharmacist at least twice
* living within the area of Tromsoe city so that interviews are possible

Exclusion Criteria

* none as patients are already enrolled in another study

Primary outcomes:
measure: Qualitative evaluation of the impact of pharmacist follow-up via interviews with the participating patients
timeFrame: 3 months or 1 year
Secondary outcomes:
Other outcomes:
Locations:
city: Tromso
country: Norway
facility: University of Tromsoe
Study officials:
affiliation: University of Tromso
name: Lars Smaabrekke, PhD
role: PRINCIPAL_INVESTIGATOR
affiliation: Hospital Pharmacy of North Norway Trust
name: Beate H Garcia, PhD
role: STUDY_CHAIR
References:
citation: Garcia BH, Storli SL, Smabrekke L. A pharmacist-led follow-up program for patients with coronary heart disease in North Norway--a qualitative study exploring patient experiences. BMC Res Notes. 2014 Mar 29;7:197. doi: 10.1186/1756-0500-7-197.